3.48000 EUR
0.08
2.25%
Last update Dec 16, 4:05 PM CET
Market closed
Day range
3.46000
3.48000
Previous close
3.56000
Open
3.46000
Access this stock data via API
Subscribe
Nervgen Pharma Corp.
3.48
0.08
2.25%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 2.7M 1.7M 1.9M 2.8M
Selling general and admin 1.1M 2.3M 1.8M 1.4M
Other operating expenses
Operating income -3.8M -4.0M -3.7M -4.2M
Non operating interest income
Income 47.7K 53.8K 66.7K 105.8K
Expense
Other income expense 1.2M -1.7M 1.2M -1.2M
Pretax income -2.6M -5.6M -2.4M -5.3M
Tax provision
Net income -2.6M -5.6M -2.4M -5.3M
Basic EPS -0.1 -0.1 -0.1
Diluted EPS -0.1 -0.1 -0.1
Basic average shares 45.3M 44.5M 43.7M
Diluted average shares 45.3M 44.5M 43.7M
EBITDA -5.0M -2.3M -4.9M -3.0M
Net income from continuing op. -2.6M -5.6M -2.4M -5.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 8 hours 5 minutes

23:54
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).